Infant formula as a solid lipid dose form for enhancement of the oral bioavailability of cannabidiol for paediatric patients.

MLA

Huang, Shouyuan, et al. “Infant Formula as a Solid Lipid Dose Form for Enhancement of the Oral Bioavailability of Cannabidiol for Paediatric Patients.” International Journal of Pharmaceutics, vol. 660, July 2024, p. 124257. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2024.124257.

APA

Huang, S., Pham, A. C., Salim, M., Eason, T., Ramirez, G., & Boyd, B. J. (2024). Infant formula as a solid lipid dose form for enhancement of the oral bioavailability of cannabidiol for paediatric patients. International Journal of Pharmaceutics, 660, 124257. https://doi.org/10.1016/j.ijpharm.2024.124257

Chicago

Huang, Shouyuan, Anna C Pham, Malinda Salim, Thomas Eason, Gisela Ramirez, and Ben J Boyd. 2024. “Infant Formula as a Solid Lipid Dose Form for Enhancement of the Oral Bioavailability of Cannabidiol for Paediatric Patients.” International Journal of Pharmaceutics 660 (July): 124257. doi:10.1016/j.ijpharm.2024.124257.